Co-administration with heparin in the following patients:
- Target patients when treating acute coronary syndrome
- Patients undergoing percutaneous coronary angioplasty (PTCA) or atherectomy surgery
This drug has been shown to reduce the incidence of death, myocardial infarction, or combined endpoint of refractory ischemia/re-cardiac procedure.